Ownership history in Opus Capital Group, LLC · 13 quarters on record
This page tracks every 13F SEC filing in which Opus Capital Group, LLC reported a position in Sellas Life Sciences Gro (SLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 317,100 | +67,100 | +26.8% | 0.13% | $1.2M | $3.77 |
| 2025 Q3 | ADDED | 250,000 | +10,000 | +4.2% | 0.05% | $403K | $1.61 |
| 2025 Q2 | ADDED | 240,000 | +500 | +0.2% | 0.06% | $526K | $2.19 |
| 2025 Q1 | ADDED | 239,500 | +1,000 | +0.4% | 0.03% | $259K | $1.08 |
| 2024 Q4 | ADDED | 238,500 | +12,400 | +5.5% | 0.03% | $248K | $1.04 |
| 2024 Q3 | ADDED | 226,100 | +5,100 | +2.3% | 0.04% | $283K | $1.25 |
| 2024 Q2 | ADDED | 221,000 | +20,400 | +10.2% | 0.04% | $263K | $1.19 |
| 2024 Q1 | ADDED | 200,600 | +65,600 | +48.6% | 0.03% | $203K | $1.01 |
| 2023 Q4 | ADDED | 135,000 | +100,500 | +291.3% | 0.02% | $143K | $1.06 |
| 2023 Q3 | ADDED | 34,500 | +3,500 | +11.3% | 0.01% | $57K | $1.64 |
As of 2025 Q4 — sorted by position size